Poly MedicureNSE:POLYMED +0.60%92 Interest Coverage is 11.26 as of Mar. 2026, which is 44% below its 10-year median of 19.94. GuruFocus rates NSE:POLYMED with a GF Score™ of 92/100 and a GF Value™ of ₹2,310.15 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 466 Medical Devices & Instruments companies, Poly Medicure ranks worse than 60.94% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Poly Medicure's
Operating Income
for the
three
months ended in Mar. 2026 was ₹722 Mil. Poly Medicure's Interest Expense for the
three
months ended in Mar. 2026 was ₹-64 Mil.
Poly Medicure's interest coverage for the quarter that ended in Mar. 2026 was 11.26.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Poly Medicure's Interest Coverage or its related term are showing as below:
NSE:POLYMED'
s Interest Coverage Range Over the Past 10 Years
Min: 7.06 Med: 19.94 Max: 44.06
Current: 9.32
NSE:POLYMED's Interest Coverage is ranked worse than 60.94% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 15.875
vs NSE:POLYMED: 9.32
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Poly Medicure Interest Coverage Related Terms
Poly Medicure Interest Coverage Historical Data
* Premium members only.
The historical data trend for Poly Medicure's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
NSE:POLYMED vs ISRG, BDX, MDLN: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, Poly Medicure's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Poly Medicure Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Poly Medicure's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Poly Medicure's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Poly Medicure (NSE:POLYMED) has a Interest Coverage of 11.26 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Poly Medicure and its competitors. This is 44% below median its historical median of 19.94. Over the past decade, Poly Medicure's Interest Coverage has ranged from 7.06 to 44.06. According to the industry distribution chart, Poly Medicure ranks #284 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 60.9%.
Is Poly Medicure's Interest Coverage too high?
Poly Medicure's current Interest Coverage of 11.26 is 44% below median its 10-year median of 19.94. Over the past 10 years, this metric has ranged from a low of 7.06 to a high of 44.06. The Medical Devices & Instruments industry median Interest Coverage is 15.88. Poly Medicure's value of 11.26 is 29.1% below this industry median. Based on the distribution chart, Poly Medicure ranks #284 out of 466 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Poly Medicure has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Poly Medicure's Interest Coverage compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Poly Medicure ranks #284 out of 466 companies for Interest Coverage. This places Poly Medicure in the lower half of its industry. The industry median Interest Coverage is 15.88. Poly Medicure's value of 11.26 is 29.1% below this benchmark. Historically, Poly Medicure's own Interest Coverage has ranged from 7.06 to 44.06 over the past decade. While the company's 10-year median is 19.94 vs. the industry median of 15.88, Poly Medicure has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Poly Medicure's current Interest Coverage of 11.26 is 29.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Poly Medicure and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Poly Medicure's current Interest Coverage is 11.26, which is 44% below median its own 10-year median of 19.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poly Medicure stock overvalued right now?
Based on GuruFocus' analysis, Poly Medicure (NSE:POLYMED) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹2,310.15, compared to a current price of ₹1,687.80 — trading 26.9% below its estimated fair value. The current Interest Coverage is 11.26, which is 44% below median its 10-year median of 19.94 and 29.1% below the Medical Devices & Instruments industry median of 15.88. Poly Medicure's overall GF Score™ is 92/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Poly Medicure (NSE:POLYMED), the current Interest Coverage is 11.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Poly Medicure (NSE:POLYMED) Overvalued in 2026?
Based on GuruFocus' analysis, Poly Medicure stock appears to be undervalued.
The current stock price of ₹1,687.80 is trading 26.9% below its estimated GF Value™ of ₹2,310.15.
GuruFocus considers Poly Medicure to be Modestly Undervalued.
Key valuation signals for NSE:POLYMED:
Interest Coverage: 11.26 (44% below median its 10-year median of 19.94)
GF Value™: ₹2,310.15 vs. price of ₹1,687.80 (26.9% below fair value)
Industry Position: 29.1% below the Medical Devices & Instruments median (#284 of 466)
No single metric tells the full story. See the NSE:POLYMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, vascular access, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.
92GF Score
Get the complete analysis for NSE:POLYMED
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:POLYMED has been successfully added to your 
